Clinical Trial Update: Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV Infection [Phase 2, Phase 3]

View source ↗

Summary

Randomized, open-label Phase 2/3 study evaluating the safety and efficacy of Sofosbuvir plus Ribavirin versus EHCV containing Sofosbuvir, Ribavirin, and a Natur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Egyptian Liver Hospital | Conditions: Hepatitis c | Phase 2, Phase 3 | Status: COMPLETED